Table 5.
Association between ALT levels and hypertension prevalence among women
| ALT levels (U/L) | Hypertensive, n (%) | Age-adjusted OR (95% CI) | Model I | Model II |
|---|---|---|---|---|
| Multi-adjusted OR (95% CI) | Multi-adjusted OR (95% CI) | |||
| Group I | ||||
| 0–40 | 257,764 (2.48) | 1 | 1 | 1 |
| 40.01– | 27,691 (4.64) | 1.91 (1.88,1.93) | 1.56 (1.54,1.58) | 1.52 (1.50,1.54) |
| Group II | ||||
| 0–20 | 162,779 (2.27) | 1 | 1 | 1 |
| 20.01–40 | 94,985 (2.93) | 1.27 (1.26,1.28) | 1.17 (1.16,1.18) | 1.17 (1.16,1.18) |
| 40.01–60 | 15,838 (4.45) | 1.94 (1.91,1.97) | 1.59 (1.57,1.62) | 1.56 (1.53,1.58) |
| 60.01–80 | 5730 (4.62) | 2.08 (2.02,2.14) | 1.64 (1.60,1.69) | 1.59 (1.55,1.64) |
| 80.01– | 6123 (5.22) | 2.46 (2.40,2.53) | 1.87 (1.82,1.93) | 1.79 (1.74,1.84) |
| P for trend† | < 0.001 | < 0.001 | < 0.001 |
ALT: alanine aminotransferase; OR: odds ratios; CI: confidence interval
Model I: Adjusted for age, sex, ethnicity, area, education, body mass index, average salt consumption, history of diabetes, overall pressure and hepatitis B surface antigen status
Model II: add fasting blood glucose concentration as a new covariate based on Model I
†P for trend were calculated by setting categorized ALT levels as a continuous variable